TRIM38 inhibits TNFα- and IL-1β–triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3
Ming‐Ming Hu(Wuhan University), Hong‐Bing Shu(Wuhan University), Zhe-Fu Huang(Chinese Academy of Sciences), Shi‐Meng Liu(Peking University), Yan‐Yi Wang(Chinese Academy of Sciences), Bo Zhong(Wuhan University), Qing Yang(Ministry of Education of the People's Republic of China), Jing Zhang(Peking University), Xiaodong Zhang(Wuhan University), Yu Zhang(Wuhan University), Heng Lin(Guangdong Medical College)
Cited by 151
Related Papers
SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response
|Cellular and Molecular Immunology|2020|220
CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer
|Nature Communications|2020|206
USP13 negatively regulates antiviral responses by deubiquitinating STING
|Nature Communications|2017|194
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
|Journal of Hematology & Oncology|2022|178